Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations.
Parkinson’s disease
association study
genetic fine mapping
risk loci
sequencing
Journal
Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537
Informations de publication
Date de publication:
03 03 2021
03 03 2021
Historique:
received:
29
05
2020
revised:
13
08
2020
accepted:
09
09
2020
pubmed:
23
12
2020
medline:
20
4
2021
entrez:
22
12
2020
Statut:
ppublish
Résumé
Genome-wide association studies (GWAS) have identified numerous loci associated with Parkinson's disease. The specific genes and variants that drive the associations within the vast majority of these loci are unknown. We aimed to perform a comprehensive analysis of selected genes to determine the potential role of rare and common genetic variants within these loci. We fully sequenced 32 genes from 25 loci previously associated with Parkinson's disease in 2657 patients and 3647 controls from three cohorts. Capture was done using molecular inversion probes targeting the exons, exon-intron boundaries and untranslated regions (UTRs) of the genes of interest, followed by sequencing. Quality control was performed to include only high-quality variants. We examined the role of rare variants (minor allele frequency < 0.01) using optimized sequence Kernel association tests. The association of common variants was estimated using regression models adjusted for age, sex and ethnicity as required in each cohort, followed by a meta-analysis. After Bonferroni correction, we identified a burden of rare variants in SYT11, FGF20 and GCH1 associated with Parkinson's disease. Nominal associations were identified in 21 additional genes. Previous reports suggested that the SYT11 GWAS association is driven by variants in the nearby GBA gene. However, the association of SYT11 was mainly driven by a rare 3' UTR variant (rs945006601) and was independent of GBA variants (P = 5.23 × 10-5 after exclusion of all GBA variant carriers). The association of FGF20 was driven by a rare 5' UTR variant (rs1034608171) located in the promoter region. The previously reported association of GCH1 with Parkinson's disease is driven by rare non-synonymous variants, some of which are known to cause dopamine-responsive dystonia. We also identified two LRRK2 variants, p.Arg793Met and p.Gln1353Lys, in 10 and eight controls, respectively, but not in patients. We identified common variants associated with Parkinson's disease in MAPT, TMEM175, BST1, SNCA and GPNMB, which are all in strong linkage disequilibrium with known GWAS hits in their respective loci. A common coding PM20D1 variant, p.Ile149Val, was nominally associated with reduced risk of Parkinson's disease (odds ratio 0.73, 95% confidence interval 0.60-0.89, P = 1.161 × 10-3). This variant is not in linkage disequilibrium with the top GWAS hits within this locus and may represent a novel association. These results further demonstrate the importance of fine mapping of GWAS loci, and suggest that SYT11, FGF20, and potentially PM20D1, BST1 and GPNMB should be considered for future studies as possible Parkinson's disease-related genes.
Identifiants
pubmed: 33349842
pii: 6043679
doi: 10.1093/brain/awaa401
pmc: PMC7940168
doi:
Substances chimiques
FGF20 protein, human
0
SYT11 protein, human
0
Synaptotagmins
134193-27-4
Fibroblast Growth Factors
62031-54-3
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
462-472Subventions
Organisme : NINDS NIH HHS
ID : K02 NS080915
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000040
Pays : United States
Organisme : CIHR
ID : FDN 154301
Pays : Canada
Informations de copyright
© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
Lancet. 2011 Feb 19;377(9766):641-9
pubmed: 21292315
N Engl J Med. 2009 Oct 22;361(17):1651-61
pubmed: 19846850
Neuron. 2013 Feb 6;77(3):425-39
pubmed: 23395371
Clin Genet. 2018 Mar;93(3):603-612
pubmed: 28862745
Genome Biol. 2017 Jan 30;18(1):22
pubmed: 28137300
Science. 1997 Jun 27;276(5321):2045-7
pubmed: 9197268
Mov Disord. 2018 Dec;33(12):1968-1970
pubmed: 30452786
Am J Hum Genet. 2016 Mar 3;98(3):500-513
pubmed: 26942284
Mov Disord. 2018 Nov;33(11):1821-1823
pubmed: 30302829
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Neuroscience. 2015 Aug 27;302:89-102
pubmed: 25450953
Ann Neurol. 2020 Jan;87(1):139-153
pubmed: 31658403
Hum Mol Genet. 2019 Oct 1;28(19):3244-3254
pubmed: 31261387
Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):E9115-E9124
pubmed: 30209220
EMBO Rep. 2016 Jan;17(1):47-63
pubmed: 26589353
Arch Neurol. 2010 Mar;67(3):347-52
pubmed: 20212233
Nat Commun. 2018 Jan 8;9(1):81
pubmed: 29311685
Neurol Genet. 2020 Jan 9;6(1):385
pubmed: 32042909
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nature. 2016 May 5;533(7601):95-9
pubmed: 27096366
Neuron. 2004 Nov 18;44(4):595-600
pubmed: 15541308
Lancet Neurol. 2019 Dec;18(12):1091-1102
pubmed: 31701892
Eur J Med Genet. 2019 Jan;62(1):65-69
pubmed: 29842932
Mol Neurodegener. 2015 Jul 14;10:28
pubmed: 26170022
Nat Genet. 2009 Dec;41(12):1308-12
pubmed: 19915575
Glia. 2017 Oct;65(10):1656-1667
pubmed: 28686317
Mov Disord. 2009 Feb 15;24(3):455-9
pubmed: 19133659
Front Neuroanat. 2015 Apr 02;9:32
pubmed: 25883554
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Biochem Biophys Res Commun. 2014 Sep 19;452(2):226-35
pubmed: 24950403
Cell Death Differ. 2016 Apr;23(4):596-607
pubmed: 26450452
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Mov Disord. 2018 Jul;33(6):1016-1020
pubmed: 29756641
Brain. 2014 Sep;137(Pt 9):2480-92
pubmed: 24993959
Nat Genet. 2009 Dec;41(12):1303-7
pubmed: 19915576
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Neurobiol Dis. 2020 Apr;137:104782
pubmed: 31991247
Pharmacol Ther. 2014 Nov;144(2):123-33
pubmed: 24854598
Brain. 2017 Jul 1;140(7):e41
pubmed: 28582483
Arq Neuropsiquiatr. 2019 Feb;77(2):73-79
pubmed: 30810589
Arch Neurol. 2012 Jan;69(1):105-10
pubmed: 22232350
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
NPJ Parkinsons Dis. 2016;2:
pubmed: 27110593
Steroids. 2018 May;133:102-107
pubmed: 29097143
Nature. 2017 Jul 27;547(7664):472-475
pubmed: 28723891
J Parkinsons Dis. 2020;10(1):301-313
pubmed: 31868683
J Neurol. 2018 Aug;265(8):1860-1870
pubmed: 29948246
Neurology. 2011 Jun 7;76(23):2002-9
pubmed: 21646627
Neurobiol Aging. 2016 Sep;45:212.e13-212.e17
pubmed: 27236598
Nat Genet. 2017 Oct;49(10):1511-1516
pubmed: 28892059
Nat Genet. 2014 Sep;46(9):989-93
pubmed: 25064009
Nature. 2011 May 5;473(7345):43-9
pubmed: 21441907
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Exp Dermatol. 2009 Jul;18(7):586-95
pubmed: 19320736
Cell. 2016 Jul 14;166(2):424-435
pubmed: 27374330
Ann Neurol. 2020 Apr;87(4):584-598
pubmed: 31976583
Neurobiol Aging. 2016 Sep;45:212.e5-212.e11
pubmed: 27255555
Science. 2012 Dec 21;338(6114):1619-22
pubmed: 23160955
Front Mol Neurosci. 2017 Mar 13;10:47
pubmed: 28348516
Cell. 2015 Aug 27;162(5):1101-12
pubmed: 26317472
Nat Genet. 2016 Sep;48(9):1037-42
pubmed: 27455347
Am J Hum Genet. 2008 Feb;82(2):283-9
pubmed: 18252210
Curr Neurol Neurosci Rep. 2018 Apr 3;18(5):21
pubmed: 29616350
Bioinformatics. 2015 Nov 1;31(21):3555-7
pubmed: 26139635
Lancet Neurol. 2011 Aug;10(8):721-33
pubmed: 21777827
Am J Hum Genet. 2012 Aug 10;91(2):224-37
pubmed: 22863193
Genome Res. 2015 Mar;25(3):305-15
pubmed: 25637381
Front Mol Neurosci. 2013 May 31;6:15
pubmed: 23754977
Nat Commun. 2016 Jun 09;7:11803
pubmed: 27278822
Parkinsonism Relat Disord. 2015 Apr;21(4):394-7
pubmed: 25634433
Neurobiol Aging. 2019 Jan;73:231.e1-231.e6
pubmed: 30314816
Brain. 2015 May;138(Pt 5):e349
pubmed: 25497597
Brain. 2005 Dec;128(Pt 12):2786-96
pubmed: 16272164
Neurobiol Aging. 2018 Nov;71:267.e7-267.e10
pubmed: 30146349